The role of the HIF-1α transcription factor in increased cell division at physiological oxygen tensions

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Carrera, Samantha ^a,d   Senra, Joana ^b   Acosta, Maria Isabel ^a   Althubiti, Mohammad ^a   Hammond, Ester M ^b   De Verdier, Petra J ^c   Macip, Salvador ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; DACTINOMYCIN; DOXORUBICIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXYGEN; PROTEIN P53; HIF1A PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; OXYGEN TENSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; CELL PROLIFERATION; GENETICS; HCT116 CELL LINE; MCF 7 CELL LINE; METABOLISM; OXIDATIVE STRESS;

CELL PROLIFERATION; DACTINOMYCIN; DNA DAMAGE; DOXORUBICIN; HCT116 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; MCF-7 CELLS; OXIDATIVE STRESS; OXYGEN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84901373499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097938     Document Type: Article

References (32)

1. Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A 92: 4337-4341.
2. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, et al. (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5: 741-747. (Pubitemid 36986782)
3. Estrada JC, Albo C, Benguria A, Dopazo A, Lopez-Romero P, et al. (2012) Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ 19: 743-755.
4. Carrera S, de Verdier PJ, Khan Z, Zhao B, Mahale A, et al. (2010) Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis. J Biol Chem 285: 13658-13665.
5. Semenza GL, Wang GL (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12: 5447-5454.
6. Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Activation of the HIF pathway in cancer. Curr Opin Genet Dev 11: 293-299. (Pubitemid 32480296)
7. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408.
8. Rankin EB, Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15: 678-685. (Pubitemid 351405072)
9. Richard DE, Berra E, Gothié E, Roux D, Pouysségur J (1999) p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. The Journal of biological chemistry 274: 32631-32637. (Pubitemid 129535289)
10. Minet E, Arnould T, Michel G, Roland I, Mottet D, et al. (2000) ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS letters 468: 53-58. (Pubitemid 30101681)
11. Sutton KM, Hayat S, Chau N-M, Cook S, Pouyssegur J, et al. (2007) Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene 26: 3920-3929. (Pubitemid 46884295)
12. Kaelin WG Jr (2008) The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 8: 865-873.
13. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer research 59: 5830-5835.
14. Jiang BH, Semenza GL, Bauer C, Marti HH (1996) Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. The American journal of physiology 271: C1172-1180.
15. Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C (2011) Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med 15: 1239-1253.
16. Ameri K, Burke B, Lewis CE, Harris AL (2002) Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia: role of HIF-1. British Journal of Cancer 87: 1173-1181. (Pubitemid 35422721)
17. Hall EJ, Giaccia AJ (2005) Radiobiology for the radiologist Lippincott Williams & Wilkins. 88-89 p.
18. Sang N, Stiehl DP, Bohensky J, Leshchinsky I, Srinivas V, et al. (2003) MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem 278: 14013-14019. (Pubitemid 36799945)
19. Ren H, Accili D, Duan C (2010) Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways. Proceedings of the National Academy of Sciences 107: 5857-5862.
20. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283. (Pubitemid 46474662)
21. Lee K, Qian DZ, Rey S, Wei H, Liu JO, et al. (2009) Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proceedings of the National Academy of Sciences of the United States of America 106: 2353-2358.
22. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, et al. (1998) p53 inhibits hypoxia-inducible factor-stimulated transcription. The Journal of biological chemistry 273: 11995-11998. (Pubitemid 28240554)
23. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, et al. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14: 34-44. (Pubitemid 30051577)
24. Sermeus A, Michiels C (2011) Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis 2: e164.
25. Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, et al. (2006) Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66: 1684-1936.
26. Ehrismann D, Flashman E, Genn DN, Mathioudakis N, Hewitson KS, et al. (2007) Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. The Biochemical journal 401: 227-234. (Pubitemid 46114616)
27. Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J (2003) Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases. Journal of Biological Chemistry 279: 9899-9904. (Pubitemid 38372589)
28. Weinberg RL, Veprintsev DB, Bycroft M, Fersht AR (2005) Comparative binding of p53 to its promoter and DNA recognition elements. J Mol Biol 348: 589-596. (Pubitemid 40515671)
29. Lofstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, et al. (2007) Hypoxia inducible factor-2alpha in cancer. Cell Cycle 6: 919-926.
30. Doroshow JH, Locker GY, Ifrim I, Myers CE (1981) Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest 68: 1053-1064. (Pubitemid 11023534)
31. Cao Y, Eble JM, Moon E, Yuan H, Weitzel DH, et al. (2013) Tumor Cells Upregulate Normoxic HIF-1alpha in Response to Doxorubicin. Cancer Res.
32. Xia Y, Choi HK, Lee K (2012) Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Eur J Med Chem 49: 24-40.